Pamela S Becker

36PUBLICATIONS
106CO-AUTHORS
Haematological tumoursMolecular targetsTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

|Apr 22, 2026
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Jul 13, 2025
Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemia.

Pamela S Becker

|Feb 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.

Paul B Koller, Tamer Othman, Dongyun Yang

|Jan 23, 2025
VenEx precisely predicts ven-aza response.

Pamela S Becker

Pageof 6

Frequent Collaborators

7 joint publications

Monzr M Al Malki

7 joint publications

Roland B Walter

6 joint publications

Haris Ali

6 joint publications

Ryotaro Nakamura